A Phase 1 clinical trial testing azercabtagene zapreleucel (azer-cel), TG Therapeutics’ CAR-T-cell therapy, in progressive forms of multiple sclerosis (MS) is now recruiting participants at eight sites across the U.S. The study (NCT06680037) is expected to enroll up to 32 adults with primary progressive MS…
Discussion
It’s been a few years since I’ve traveled in an airplane. Flying commercially when you depend on a wheelchair for locomotion is apparently quite the nightmare. Between that and all the accessories I travel with, as long as the distance is reasonable, I’d rather just drive. The fact that…
Low to moderate doses of vitamin D supplements may be linked to lower relapse rates in people with multiple sclerosis (MS), according to a new meta-analysis of clinical trials. Higher doses did not show the same benefit, and vitamin D supplementation overall did not significantly change disability scores. “Based on…
Long-term exposure to air pollution may increase the risk of developing multiple sclerosis (MS), while short-term exposure may worsen disease activity and disability in people who already have the condition, according to a new study. “Long-term air pollution exposure was associated with higher MS risk, and short-term exposure with…
Discussion
Living with multiple sclerosis (MS) is often described in medical terms — lesions, relapses, progression curves, and other jargon — that don’t always register in my mind. But a diagnosis is also associated with grief, a quieter and oftentimes silent reality that doesn’t hit all at once, but…
Get regular updates to your inbox.
